Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Keating

Showing results (411-420 of 436) with videos related to

Pageof 44
Sort By:
Leukemia & Lymphoma|November 9, 2001
Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survivalF J Giles, Y Shen, H M Kantarjian, et al.
Leukemia|April 29, 2015
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLLK Balakrishnan, M Peluso, M Fu, et al.
Cancer|November 1, 1986
Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Oncogene|June 6, 1996
Apoptosis suppression by bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+M C Marin, A Fernandez, R J Bick, et al.
Cancer Research|September 18, 2001
Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 geneF Bullrich, H Fujii, G Calin, et al.
Leukemia|August 21, 2012
Trisomy 12 CLLs progress through NOTCH1 mutationsV Balatti, S Lerner, L Rizzotto, et al.
Leukemia|April 24, 2013
Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53(-/-) mouse model and primary human leukemia cellsJ Liu, G Chen, L Feng, et al.
Archives of Internal Medicine|February 1, 1992
A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patientsK V Rolston, P Berkey, G P Bodey, et al.
Cancer Research|March 15, 1987
Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patientsS A Maxwell, R Kurzrock, S J Parsons, et al.
Oncogene|April 12, 2016
Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexilineP-P Liu, J Liu, W-Q Jiang, et al.
Pageof 44

Showing results (411-420 of 436) with videos related to

Sort By:
Pageof 44
Leukemia & Lymphoma|November 9, 2001
Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survivalF J Giles, Y Shen, H M Kantarjian, et al.
Leukemia|April 29, 2015
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLLK Balakrishnan, M Peluso, M Fu, et al.
Cancer|November 1, 1986
Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Oncogene|June 6, 1996
Apoptosis suppression by bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+M C Marin, A Fernandez, R J Bick, et al.
Cancer Research|September 18, 2001
Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 geneF Bullrich, H Fujii, G Calin, et al.
Leukemia|August 21, 2012
Trisomy 12 CLLs progress through NOTCH1 mutationsV Balatti, S Lerner, L Rizzotto, et al.
Leukemia|April 24, 2013
Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53(-/-) mouse model and primary human leukemia cellsJ Liu, G Chen, L Feng, et al.
Archives of Internal Medicine|February 1, 1992
A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patientsK V Rolston, P Berkey, G P Bodey, et al.
Cancer Research|March 15, 1987
Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patientsS A Maxwell, R Kurzrock, S J Parsons, et al.
Oncogene|April 12, 2016
Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexilineP-P Liu, J Liu, W-Q Jiang, et al.
Pageof 44